Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myeloid, Acute × Immunoglobulin G × 90 days × Clear all

Sponsor

Conditions

Lung Neoplasms 15 Carcinoma, Non-Small-Cell Lung 12 Ovarian Neoplasms 5 Fallopian Tube Neoplasms 5 Carcinoma, Renal Cell 5 Squamous Cell Carcinoma of Head and Neck 4 Colorectal Neoplasms 4 Carcinoma, Hepatocellular 4 Urinary Bladder Neoplasms 3 Triple Negative Breast Neoplasms 3 Pancreatic Neoplasms 3 Neoplasm Metastasis 3 Nasopharyngeal Carcinoma 3 Melanoma 3 Endometrial Neoplasms 3 Carcinoma 3 Urogenital Neoplasms 2 Urethral Neoplasms 2 Ureteral Neoplasms 2 Oropharyngeal Neoplasms 2 Mouth Neoplasms 2 Lymphoid Interstitial Pneumonia 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Colitis 2 Carcinoma, Transitional Cell 2 Carcinoma, Merkel Cell 2 Brenner Tumor 2 Breast Neoplasms 2 Brain Neoplasms 2

Interventions

venetoclax 87 Azacitidine 69 Cytarabine 52 fludarabine 43 Specimen Handling 36 Biopsy 26 Daunorubicin 25 Cyclophosphamide 25 Decitabine 24 fludarabine phosphate 22 Injections 19 Granulocyte Colony-Stimulating Factor 18 Busulfan 17 Whole-Body Irradiation 16 Stem Cell Transplantation 15 Idarubicin 15 Mycophenolic Acid 14 Melphalan 14 Tacrolimus 13 CPX-351 13 gilteritinib 11 decitabine and cedazuridine drug combination 11 Filgrastim 11 enasidenib 9 ivosidenib 8 Mitoxantrone 8 Methotrexate 8 Magnetic Resonance Spectroscopy 8 Gemtuzumab 8 Cladribine 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡